← all drugs
Ketorolac Tromethamine Injection
in shortage · Analgesia/Addiction · Snapshot: 2026-08-25
Day 3,077
of this shortage, counting from the FDA's first posting on 03/23/2018
- Manufacturers listed
- Fresenius Kabi USA, LLC, Sagent Pharmaceuticals, Alembic Pharmaceuticals, Hospira, Inc., a Pfizer Company, Hikma Pharmaceuticals USA, Inc., Baxter Healthcare, Gland Pharma Limited
- Reported reason(s)
- Delay in shipping of the drug; Other; Demand increase for the drug
- Machine-readable
- JSON for this drug
Presentations (25)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Fresenius Kabi USA, LLC | Unavailable | 08/04/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Fresenius Kabi USA, LLC | Unavailable | 08/04/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Sagent Pharmaceuticals | Limited Availability | 08/18/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) | Alembic Pharmaceuticals | Available | 05/15/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Fresenius Kabi USA, LLC | Unavailable | 08/04/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Hospira, Inc., a Pfizer Company | Unavailable | 08/07/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) | Alembic Pharmaceuticals | Available | 05/15/2026 |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Fresenius Kabi USA, LLC | Unavailable | 08/04/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Baxter Healthcare | Unavailable | 08/17/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Gland Pharma Limited | Available | 07/22/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Fresenius Kabi USA, LLC | Unavailable | 08/04/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Sagent Pharmaceuticals | Available | 08/18/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Gland Pharma Limited | Available | 07/22/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Fresenius Kabi USA, LLC | Available | 08/04/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Gland Pharma Limited | Available | 07/22/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Sagent Pharmaceuticals | Available | 08/18/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Gland Pharma Limited | Available | 07/22/2026 |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Hospira, Inc., a Pfizer Company | Unavailable | 08/07/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Baxter Healthcare | Unavailable | 08/17/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | Hospira, Inc., a Pfizer Company | Unavailable | 08/07/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) | Alembic Pharmaceuticals | Available | 05/15/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Gland Pharma Limited | Available | 07/22/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.